PHYTOSOMES ENHANCED THE ANTIBACTERIAL AND ANTIFUNGAL PROPERTIES OF LANTANA CAMARA

Aim: The aim of the work was to formulate Lantana camara phytosomes to improve the antimicrobial properties. Methods: L. camara phytosomes were prepared by solvent evaporation using soy lecithin (Phospholipon® 90H). The effect of surfactant Poloxamer 188 was carried out. The qualitative and quantitative analysis of the phytoconstituents was analyzed. The encapsulation efficiency and loading capacity were studied. Furthermore, the in vitro release profile was studied in ethanolic buffer. The inhibition zone diameter (IZD) was evaluated against three bacterial and two fungi. Results: The results showed that saponins were the most dominant phytochemical with about 7% on the plant leaves. The highest EE of 82.80% was obtained. In vitro release showed about 23% drug release at 60 min. The IZD results showed that L. camara had significantly higher activity against Escherichia coli and Listeria ivanovii than Staphylococcus aureus (p<0.05). The results also showed that for Candida albicans, L. camara phytosomes had significantly higher IZD than the extract (p<0.05). However, the L. camara extract and the formulations showed no activity against the Aspergillus flavus. Conclusions: Phytosomes enhanced the antimicrobial properties of L. camara and could serve as a good delivery system for this herbal drug

Bio-survey of Plankton as indicators of water quality for recreational activities in Calabar River, Nigeria

With the increasing recognition of Calabar as a global tourist destination, the suitability of Calabar River for recreational activities by tourists was investigated. The aim was to use phytoplankton and zooplankton characteristics to assess the water quality of the Calabar River. Phytoplankton and zooplankton samples were collected from four stations along the river and carried in plastic containers at 4oC to the laboratory for taxonomic and diversity index analyses. Water samples were also collected from the sampling stations for physico-chemicalanalysis. In total, 331 phytoplankton individuals were identified from sixty-six species in sixty genera and six taxonomic groups. The most abundant taxon was Bacillariophyceae 212 (64.05%), followed by Cyanophyceae 42 (12.69%), Chlorophyceae 40 (12.08%); Dinophyceae 16 (4.83%); Chrysophyceae 12 (3.63%) and Xanthophyceae 9 (2.72%). Similarly, the diatoms were highest in species richness (54.55%) followed by Cyanophyceae (18.18%),Chlorophyceae (12.12%), Dinophyceae (6.06%), Chrysophyceae (4.55%), and Xanthophyceae (4.55%). Among the zooplankton, the Copepods were the most abundant (54.89%). Others were Protozoa (14.13%), Polychaeta larvae (7.07%), Cyclopoida (5.43%), Cladocera (5.43%), Arthropoda (4.89%), Ostracoda (3.26%), Rotifera (2.72%),Malacostraca (1.09%), and Foraminiferida (1.09%). The copepods were highest in species richness (13), representing 36.11% of the total. The other zooplankton taxonomic groups were Protozoa (16.67%), Cyclopoida (11.11%), Ostracoda (8.33%), Rotifera (8.33%), Cladocera (5.56%), Malacostraca (5.56%), Arthropoda (2.78%), Polychaeta larvae (2.78%), and Foraminiferida (2.78%). We did not observe any preponderance of harmful phytoplankton or zooplankton in the Calabar River during the study. The river showed no evidence of stress beyond her carrying capacity, and there was no evidence of any harmful environmental conditions that is detrimental to recreational activities in the Calabar River. We assess Calabar River as being biologically suitable for contact recreational activities, from the point of view of her plankton characteristics

Mucoadhesive sustained delivery of diclofenac sodium using carbopol 675 and PVP admixtures as mucoadhesive motif

The mucoadhesiveness, swelling characteristics and release profile of diclofenac sodium from mucoadhesive tablets prepared with Carbopol 675 and polyvinyl pyrrolidone (PVP) and their physical mixtures were studied to evaluate their applicability in sustained drug delivery. The ex-vivo mucoadhesive strengths of the tablet compacts were determined by tensiometry using Lecomte du Nuoy tensiometer and everted pig jejunum. Release studies were carried out in three different pH media (1.2, 7.0 and 7.5). The results of mucoadhesive test revealed that tablets formulated from 1:1 physical mixture of Carbopol 675 and PVP had the highest mucoadhesive strength, which showed they bound tightly to the mucus pig jejunum. Their low swelling and release behaviours also indicated that the tablet compacts are very good candidates for sustained release formulation since release of diclofenac sodium was sustained by the compacts

Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance

Petra Obioma Nnamani,1,2 Agatha Adaora Ugwu,1 Emmanuel Chinedu Ibezim,1 Franklin Chimaobi Kenechukwu,1 Paul Achile Akpa,1 John-Dike Nwabueze Ogbonna,1 Nicholas Chinedu Obitte,3 Amelia Ngozi Odo,4 Maike Windbergs,2 Claus-Michael Lehr,2,5,6 Anthony Amaechi Attama1 1Drug Delivery and Nanomedicines Research Group, Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, Nigeria; 2Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, Saarland University, Saarbrücken, Germany; 3Department of Pharmaceutical Technology and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, 4Department of Human Kinetics and Health Education, University of Nigeria, Nsukka, Nigeria; 5PharmBioTec GmbH, 6Department of Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany Abstract: The present study aimed to develop low-dose liquisolid tablets of two antimalarial drugs artemether–lumefantrine (AL) from a nanostructured lipid carrier (NLC) of lumefantrine (LUM) and estimate the potential of AL as an oral delivery system in malariogenic Wistar mice. LUM-NLCs were prepared by hot homogenization using Precirol® ATO 5/Transcutol® HP and tallow fat/Transcutol® HP optimized systems containing 3:1 ratios of the lipids, respectively, as the matrices. LUM-NLC characteristics, including morphology, particle size, zeta potential, encapsulation efficiency, yield, pH-dependent stability, and interaction studies, were investigated. Optimized LUM-NLCs were mixed with artemether powder and other dry ingredients and the resultant powder evaluated for micromeritics. Subsequent AL liquisolid tablets were tested for in vitro drug release and in vivo antiplasmodial activity in mice infected with Plasmodium berghei berghei (NK 65). Results showed that optimized LUM-NLC were stable, spherical, polydispersed but nanometric. Percentage yield and encapsulation efficiency were ~92% and 93% for Precirol® ATO 5/Transcutol® HP batch, then 81% and 95% for tallow fat/Transcutol® HP batch while LUM was amorphous in NLC matrix. In vitro AL release from liquisolid compacts revealed initial burst release and subsequent sustained release. Liquisolid tablet compacts formulated with Precirol® ATO 5/Transcutol® HP-AL4 achieved higher LUM release in simulated intestinal fluid (84.32%) than tallow fat/Transcutol® HP-BL3 (77.9%). Non-Fickian (anomalous) diffusion and super case II transport were the predominant mechanisms of drug release. Equal parasitemia reduction was observed for both batches of tablet compacts (~92%), superior to the reduction obtained with commercial antimalarial formulations: Coartem® tablets (86%) and chloroquine phosphate tablets (66%). No significant difference (P<0.05) in parasite reduction between double (4/24 mg/kg) and single (2/12 mg/kg) strength doses of AL compacts was observed. Our result highlights that AL could be formulated in much lower doses (4/24 mg/kg), for once-in-two days oral administration to improve patient compliance, which is currently not obtainable with conventional AL dosage forms. Keywords: malaria, artemisinin-based combination therapy, antiplasmodial activity, liquisolid compacts, nanostructured lipid carrier

Bacillus subtilis M4 decreases plant susceptibility towards fungal pathogens by increasing host resistance associated with differential gene expression

Results presented in this paper describe the ability of Bacillus subtilis strain M4 to reduce disease incidence caused by Colletotrichum lagenarium and Pythium aphanidermatum on cucumber and tomato, respectively. Disease protection in both pathosystems was most probably due to induction of resistance in the host plant since experiments were designed in order to avoid any direct contact between the biocontrol agent and the pathogen. Pre-inoculation with strain M4 thus sensitised both plants to react more efficiently to subsequent pathogen infection. In cucumber, the use of endospores provided a disease control level similar to that obtained with vegetative cells. In contrast, a mixture of lipopeptides from the surfactin, iturin and fengycin families showed no resistance-inducing potential. Interestingly, treatment with strain M4 was also associated with significant changes in gene transcription in the host plant as revealed by cDNA-AFLP analyses. Several AFLP fragments corresponded to genes not expressed in control plants and specifically induced by the Bacillus treatment. In support to the macroscopic protective effect, this differential accumulation of mRNA also illustrates the plant reaction following perception of strain M4, and constitutes one of the very first examples of defence-associated modifications at the transcriptional level elicited by a non-pathogenic bacterium in a host plant